Literature DB >> 8679786

Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults.

N Breslau1, T Roth, L Rosenthal, P Andreski.   

Abstract

In a longitudinal epidemiological study of young adults, we estimated the association between sleep disturbance and psychiatric disorders, cross-sectionally and prospectively. A random sample of 1200 was drawn from all 21-30-year-old members of a large health maintenance organization (HMO) in Michigan; 1007 were interviewed in 1989 and 979 were reinterviewed in 1992. Lifetime prevalence of insomnia alone was 16.6%, of hypersomnia alone, 8.2%, and of insomnia plus hypersomnia, 8%. The gender-adjusted relative risk for new onset of major depression during the follow-up period in persons with history of insomnia at baseline was 4.0 (95% confidence interval [CI] 2.2-7.0) and in persons with baseline history of hypersomnia, 2.9 (95% CI 1.5-5.6). When history of other prior depressive symptoms (e.g., psychomotor retardation or agitation, suicidal ideation) was controlled for, prior insomnia remained a significant predictor of subsequent major depression. Complaints of 2 weeks or more of insomnia nearly every night might be a useful marker of subsequent onset of major depression.

Entities:  

Mesh:

Year:  1996        PMID: 8679786     DOI: 10.1016/0006-3223(95)00188-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  478 in total

1.  Sleep disturbances in adult survivors of childhood brain tumors.

Authors:  Vikki G Nolan; Roxanna Gapstur; Cynthia R Gross; Lauren A Desain; Joseph P Neglia; Amar Gajjar; James L Klosky; Thomas E Merchant; Marilyn Stovall; Kirsten K Ness
Journal:  Qual Life Res       Date:  2012-06-06       Impact factor: 4.147

2.  Association of Markers of Inflammation with Sleep and Physical Activity Among People Living with HIV or AIDS.

Authors:  Michael D Wirth; Jason R Jaggers; Wesley D Dudgeon; James R Hébert; Shawn D Youngstedt; Steven N Blair; Gregory A Hand
Journal:  AIDS Behav       Date:  2015-06

3.  Ramelteon: a novel hypnotic indicated for the treatment of insomnia.

Authors:  Gary K Zammit
Journal:  Psychiatry (Edgmont)       Date:  2007-09

4.  Sleep Efficiency Modulates Associations Between Family Stress and Adolescent Depressive Symptoms and Negative Affect.

Authors:  Jessica J Chiang; Joanna J Kim; David M Almeida; Julienne E Bower; Ronald E Dahl; Michael R Irwin; Heather McCreath; Andrew J Fuligni
Journal:  J Adolesc Health       Date:  2017-07-17       Impact factor: 5.012

5.  Poor sleep quality increases symptoms of depression and anxiety in postpartum women.

Authors:  Michele L Okun; Roberta A Mancuso; Calvin J Hobel; Christine Dunkel Schetter; Mary Coussons-Read
Journal:  J Behav Med       Date:  2018-07-20

6.  Morbidity associated with sleep disorders in primary care: a longitudinal cohort study.

Authors:  Mari-Ann Wallander; Saga Johansson; Ana Ruigómez; Luis A García Rodríguez; Roger Jones
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

7.  The direction of longitudinal associations between sleep problems and depression symptoms: a study of twins aged 8 and 10 years.

Authors:  Alice M Gregory; Frühling V Rijsdijk; Jennifer Y F Lau; Ronald E Dahl; Thalia C Eley
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

8.  Evaluating DSM-5 Insomnia Disorder and the Treatment of Sleep Problems in a Psychiatric Population.

Authors:  Lee Seng Esmond Seow; Swapna Kamal Verma; Yee Ming Mok; Sunita Kumar; Sherilyn Chang; Pratika Satghare; Aditi Hombali; Janhavi Vaingankar; Siow Ann Chong; Mythily Subramaniam
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

9.  Depression: relationships to sleep paralysis and other sleep disturbances in a community sample.

Authors:  Mariana Szklo-Coxe; Terry Young; Laurel Finn; Emmanuel Mignot
Journal:  J Sleep Res       Date:  2007-09       Impact factor: 3.981

10.  Sleep in rheumatic diseases and other painful conditions.

Authors:  Luis F Buenaver; Michael T Smith
Journal:  Curr Treat Options Neurol       Date:  2007-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.